You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 19, 2025

Drugs with Dosage: GAS


✉ Email this page to a colleague

« Back to Dashboard


Drugs with Dosage: GAS

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity ExpirationDosage
Linde Gas Equip NOXIVENT nitric oxide GAS;INHALATION 207141-001 Oct 2, 2018 RX No Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe GAS;INHALATION
Linde Gas Equip NOXIVENT nitric oxide GAS;INHALATION 207141-002 Oct 2, 2018 AA RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe GAS;INHALATION
Mallinckrodt XENON XE 127 xenon xe-127 GAS;INHALATION 018536-001 Oct 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe GAS;INHALATION
Mallinckrodt XENON XE 127 xenon xe-127 GAS;INHALATION 018536-002 Oct 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe GAS;INHALATION
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration>Dosage
Showing 1 to 4 of 4 entries

Market Dynamics and Financial Trajectory of the Pharmaceutical Industry: A Focus on Drug Development and Delivery

Introduction

The pharmaceutical industry is a complex and dynamic sector, driven by a multitude of factors including technological advancements, regulatory changes, and shifting healthcare needs. This article delves into the market dynamics and financial trajectory of the pharmaceutical industry, with a particular focus on drug development and delivery.

Global Pharmaceutical Market Overview

The global pharmaceutical market was estimated at USD 1,482.0 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.12% from 2023 to 2030[1].

Drivers of Market Growth

Several key factors are driving the growth of the pharmaceutical market:

Increasing Chronic Disease Prevalence

The rising prevalence of chronic diseases such as diabetes, hypertension, and cancer is a significant driver. This increase in chronic conditions necessitates the development and use of more pharmaceuticals, contributing to market growth[1][4].

Rising Geriatric Population

The global geriatric population is increasing, leading to higher demand for pharmaceuticals. Older populations often require more medications, which boosts the market[1][4].

Healthcare Spending and Affordability

Government organizations are increasing healthcare spending, and there is a growing emphasis on making pharmaceuticals more affordable. This includes efforts to reduce prescription drug prices and improve access to care[1].

Pharmaceutical Market Segments

The pharmaceutical market can be segmented into several key areas:

Branded vs. Generic Drugs

The branded segment dominated the market with a 67.60% revenue share in 2022. This dominance is due to the rising prevalence of chronic diseases and the approval of novel pharmaceuticals. However, the patent expiry of branded drugs and the entry of generic drugs pose challenges to this segment's growth[1].

Prescription vs. Over-the-Counter (OTC) Drugs

The prescription segment held a dominant revenue share of 87.23% in 2022. This is largely due to the increasing R&D investments in developing new pharmaceuticals for chronic diseases, which are primarily prescription-based[1].

Drug Development Costs and Financial Returns

Developing a new drug is a costly and risky endeavor:

Average Development Costs

The average out-of-pocket cost to develop one drug is between $280 million and $380 million. However, when including capital costs and the costs of failed drugs, the total cost can range from $2.4 billion to $3.2 billion[2].

Financial Returns and ROI

Despite the high costs, successful drugs can generate substantial revenue. However, the return on investment (ROI) for pharmaceutical R&D has been declining, with a forecasted ROI of just 1.2% for the 20 largest pharmaceutical companies in 2022[5].

Investment Landscape

Private investment, particularly from venture capital, is crucial for overcoming the 'translation gap' between early research and late-stage clinical development. Big biopharma companies play a significant role in financing these late-stage phases[2].

Pharmaceutical Drug Delivery Market

The global pharmaceutical drug delivery market is expected to grow significantly:

Market Size and Growth

The market is forecasted to grow from USD 1,949.4 billion in 2024 to USD 2,546.0 billion by 2029, driven by a CAGR of 5.5%. This growth is fueled by the rising incidence of chronic diseases, new product launches, and increased investment in R&D[4].

Modernization of Drug Delivery Technologies

Advancements in drug delivery technologies, such as patient-preferred home-based care and supportive reimbursement policies, are also driving market growth. These innovations improve patient comfort and compliance, further propelling the market[4].

Impact of Regulatory and Technological Changes

Regulatory and technological changes significantly influence the pharmaceutical market:

Regulatory Hurdles

Stricter regulatory hurdles and shorter exclusivity periods are among the factors contributing to the declining ROI for pharmaceutical R&D. Companies must navigate these challenges to bring new drugs to market[5].

Leveraging Data and Digital Technology

The ability to leverage data and digital technology to inform clinical trial designs and improve R&D efficiency is crucial. This includes using patient-reported outcomes and data from past trials to accelerate research[3].

Regional Spending and Usage Trends

Global spending on medicines is expected to increase, driven by various regional trends:

Developed Markets

In developed markets, the availability and use of innovative therapeutics are key drivers of spending growth. Despite losses of exclusivity and the lower costs of generics and biosimilars, the overall spending is expected to rise due to the higher clinical value of new medicines[3].

Emerging Markets

In emerging markets, the growth is driven by increasing access to medicines and rising healthcare spending. The mix of spending growth between volume-driven growth and mix-driven changes in therapy costs is shifting towards more expensive therapies with higher clinical value[3].

Future Outlook and Challenges

The future of the pharmaceutical industry is marked by both opportunities and challenges:

Increasing Demand for Innovative Therapeutics

The escalating global burden of chronic diseases and the need for novel therapeutics will continue to drive the market. Breakthrough therapies launched over the past decade are reshaping patient care, and more such innovations are expected[3].

Sustainability of R&D Model

The declining ROI for pharmaceutical R&D raises concerns about the sustainability of the current model. Companies must adapt to changing regulatory landscapes and leverage technological advancements to maintain profitability[5].

Key Takeaways

  • The global pharmaceutical market is expected to grow significantly, driven by chronic disease prevalence, a rising geriatric population, and increased healthcare spending.
  • The branded segment dominates the market, but faces challenges from generic drugs.
  • Drug development is costly and risky, with declining ROI for R&D.
  • The pharmaceutical drug delivery market is growing due to advancements in technology and increasing patient demand.
  • Regulatory and technological changes are crucial for navigating the market.

FAQs

What is the projected growth rate of the global pharmaceutical market from 2023 to 2030?

The global pharmaceutical market is expected to grow at a CAGR of 6.12% from 2023 to 2030[1].

What are the main drivers of the pharmaceutical market growth?

The main drivers include the increasing prevalence of chronic diseases, a rising geriatric population, and increased healthcare spending by government organizations[1].

How much does it cost to develop a new drug?

The average out-of-pocket cost to develop one drug is between $280 million and $380 million, but total costs including capital and failed drugs can range from $2.4 billion to $3.2 billion[2].

What is the forecasted ROI for pharmaceutical R&D in 2022?

The forecasted ROI for pharmaceutical R&D in 2022 was just 1.2%, a significant drop from previous years[5].

How is the pharmaceutical drug delivery market expected to grow by 2029?

The global pharmaceutical drug delivery market is expected to grow from USD 1,949.4 billion in 2024 to USD 2,546.0 billion by 2029, driven by a CAGR of 5.5%[4].

Sources

  1. Grand View Research - Pharmaceutical Market Size, Share & Trends Report, 2030
  2. RAND - The Financial Ecosystem of Pharmaceutical R&D
  3. IQVIA - The Global Use of Medicines 2024: Outlook to 2028
  4. MarketsandMarkets - Pharmaceutical Drug Delivery Market Growth, Drivers & Opportunities
  5. DrugBank Blog - Investment Trends in Pharmaceutical Research

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.